Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001551

Options or other derivatives

  • Chief Business - Strategy Off acquired 272,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lin Patrick Chief Business - Strategy Off 2025-10-01 Grant or award · Restricted Stock Units +68,000 68,000 D
Lin Patrick Chief Business - Strategy Off 2025-10-01 Grant or award · Stock Options (Right to Buy) +204,000 204,000 D
Loading xslF345X05/form4.xml…